Lee Shapiro

Background

Lee Shapiro is Co-Founder and Managing Partner of 7wire Ventures, a Chicago-based venture capital firm focused exclusively on digital health that he co-founded with Glen Tullman in 2013 ¹². Shapiro and Tullman had previously worked together for more than 30 years across more than 25 companies ³.

Before entering venture capital, Shapiro had an extensive career spanning law, real estate, banking, and healthcare technology. He earned a BS in Accounting from the University of Illinois Urbana-Champaign and a JD from the University of Chicago Law School ⁴⁵. He is both a certified public accountant and licensed attorney ⁵. He began his career practicing commercial law at Barack, Ferrazzano, Kirschbaum, Perlman & Nagelberg in Chicago ⁴. He subsequently served as Vice Chairman of City Financial Bancorp and President of SES Properties, Inc. ⁴. He then became Chief Operating Officer of Douglas Elliman-Beitler, a commercial office management and development company, where he directed all business activities throughout the U.S. ⁴.

Shapiro joined Allscripts Healthcare Solutions in April 2000 and served as President from 2001 through 2012 ³⁶. During his tenure, he oversaw the company’s strategy, international operations, business development and partnerships, and was central to over $4 billion in mergers, acquisitions, and financings ³⁴. After departing Allscripts in late 2012, he and Tullman devoted their attention to investing through 7wire Ventures ².

Beyond his role at 7wire, Shapiro served as Chief Financial Officer of Livongo Health from December 2018 to November 2020 ³⁷. Prior to stepping in as CFO, he had served on Livongo’s board since its launch in 2013, chairing the audit committee and serving on the compensation committee ³. As CFO, he led Livongo’s 2019 IPO, a successful secondary offering, a $550 million convertible debt raise, and the company’s $18.5 billion merger agreement with Teladoc Health — the highest valuation of any healthcare technology company based on revenue multiples at the time ³⁷. The share price of $159 at the time of the merger was over six times the IPO price just 12 months earlier ³.

Shapiro began a two-year term as Chairperson of the American Heart Association’s National Board of Directors on July 1, 2025, after previously serving as Audit Committee Chair and Treasurer ⁵. He had joined the AHA around 2012 through the Qualcomm Life Advisory Council ⁵. He has run 18 marathons, including the Boston Marathon ⁵.

Stated Thesis

Shapiro publicly describes 7wire’s investment focus as supporting “an Informed Connected Health Consumer” — the belief that technology and technology-enabled services can empower individuals to make smarter health and care decisions ¹⁸.

At the founding of 7wire, Shapiro stated: “We founded 7wire on the concept of disrupting the status quo — supporting new ideas, technologies, approaches, and business models for solving society’s most important problems” ².

In a 2024 StartUp Health Masterclass, Shapiro emphasized that understanding healthcare business fundamentals is non-negotiable for founders: “If you don’t have an understanding of reimbursement, or how doctors are paid, or what it takes to get integrated into a practice, you’re going to have trouble” ⁹. He also stressed the importance of unit economics over top-line growth: “Not every dollar of revenue is the same. What’s the margin on that dollar?” ⁹.

Shapiro has described 7wire as a relationship-driven investor, stating: “Building relationships takes time; it’s a little like dating” and “At 7wireVentures we won’t invest in the company unless we’ve gone out to dinner with a founder at least once if not multiple times” ⁹.

Inferred Thesis

Lee Shapiro’s investment behavior is essentially identical to 7wire Ventures’ overall thesis — he is not a side-bet investor or angel with a separate portfolio. His investments are made through the 7wire fund, and he personally sits on many portfolio company boards. Based on 7wire’s 28 verified portfolio investments (see firm profile for full analysis):

Sector breakdown (28 verified investments): - Chronic disease management / virtual care: 8 of 28 (29%) — Livongo, Transcarent, Parsley Health, Zerigo Health, WellTheory, CirrusMD, Medisafe, Override - Mental / behavioral health: 4 of 28 (14%) — NOCD, Brightline, Jasper Health, Caraway - Care navigation / population health: 4 of 28 (14%) — GroundGame.Health, ConsejoSano, Yaro, Lightbeam - Caregiving / aging in place: 2 of 28 (7%) — Homethrive - Health insurance / benefits: 2 of 28 (7%) — When Insurance, PayZen - Other digital health: 8 of 28 (29%) — MedArrive, FOLX Health, CareDox, Ayogo, EosHealth, ZestHealth, Truvian Sciences, Higi

100% of investments are in healthcare. The firm has zero investments outside of health-related sectors ⁸.

Stage distribution: Primarily seed and Series A for initial investments, with strong follow-on through Series B and beyond. The 2023 $217M Growth & Opportunity Fund was specifically designed for later-stage follow-on and new Series B/C investments ¹⁰.

Distinctive pattern — the “Hatch” model: Shapiro personally co-created multiple portfolio companies through 7wire’s proprietary incubation program, including Livongo, Transcarent, Homethrive, and Caraway ¹¹¹². Homethrive specifically came from Shapiro’s personal experience caring for his aging mother ¹³. This blurs the line between investor and founder — Shapiro is an operator-investor who builds companies, not just funds them.

Board engagement: Shapiro personally serves or has served on the boards of Override Health, FOLX Health, Jasper Health, PayZen, Transcarent, Click Therapeutics, Clover Health, Medidata Solutions, and Tivity Health, among others ⁵¹⁴⁴¹⁵. This is an unusually high level of direct board involvement for a managing partner.

Co-investor patterns: General Catalyst is a key co-investor, particularly through the Livongo and Transcarent partnership (Hemant Taneja co-hatched Transcarent with Tullman and Shapiro) ¹². The firm’s Connected Consumer Health Coalition — strategic LPs including Cigna, Memorial Hermann, Rush, Florida Blue, and Boeing — provides proprietary deal flow and distribution advantages ¹.

Geographic concentration: Chicago-based firm with portfolio companies distributed across the U.S., with notable concentration in Illinois and California.

Founder profile preferences: The firm targets founders addressing specific underserved populations — LGBTQIA+ community (FOLX Health), Spanish-speaking communities (ConsejoSano), children and teens (Brightline, CareDox), seniors (Homethrive), and people with specific conditions like OCD (NOCD) ⁸.

Portfolio

Lee Shapiro’s investments are made through 7wire Ventures. The following table focuses on companies where Shapiro has confirmed personal board involvement or direct investment attribution.

This table represents confirmed personal board seats and attributed investments. The full 7wire Ventures portfolio of 28+ verified investments (including Brightline, GroundGame.Health, WellTheory, Zerigo Health, MedArrive, and others) is documented in the 7wire Ventures firm profile. Investment years marked with “~” are approximate.

In Their Own Words

“We founded 7wire on the concept of disrupting the status quo — supporting new ideas, technologies, approaches, and business models for solving society’s most important problems.” — Lee Shapiro, 2013 ²

“We believe that if you can connect and communicate with one another, you can transform relationships to create value.” — Lee Shapiro, on the meaning of the firm’s name ¹⁹

“I honestly love the time that I spend talking to founders, hearing about their dreams and building businesses and helping them solve the problems they’re facing.” — Lee Shapiro, American Heart Association profile ⁵

“Building relationships takes time; it’s a little like dating.” — Lee Shapiro, StartUp Health Masterclass, 2024 ⁹

“At 7wireVentures we won’t invest in the company unless we’ve gone out to dinner with a founder at least once if not multiple times.” — Lee Shapiro, StartUp Health Masterclass, 2024 ⁹

“If you don’t have an understanding of reimbursement, or how doctors are paid, or what it takes to get integrated into a practice, you’re going to have trouble.” — Lee Shapiro, StartUp Health Masterclass, 2024 ⁹

“Not every dollar of revenue is the same. What’s the margin on that dollar?” — Lee Shapiro, StartUp Health Masterclass, 2024 ⁹

“The tourists have left the island.” — Lee Shapiro, on market conditions in digital health, StartUp Health Masterclass, 2024 ⁹

“My recommendation is to hire slowly because it’s better to work a little harder.” — Lee Shapiro, StartUp Health Masterclass, 2024 ⁹

“What you’re doing is hard. It’s hard work and it’s a labor of love.” — Lee Shapiro, to health innovation founders, StartUp Health Masterclass, 2024 ⁹

“The Clover Assistant technology platform is a distinctive asset that brings unique value to its network physicians and plan members.” — Lee Shapiro, on joining Clover Health’s board, January 2021 ⁶

What Founders Say

“Lee Shapiro has been an incredible partner to Clover, bringing a mix of discipline, heart, and experience that’s hard to replicate. His belief in our mission and his leadership on the Board have helped us navigate critical chapters of our journey.” — Vivek Garipalli, Executive Chairperson and Founder of Clover Health, April 2025 ²⁰

“Lee’s leadership and more than two decades of experience in managing leading healthcare companies will be an amazing asset to Clover Health.” — Vivek Garipalli, CEO of Clover Health, on Shapiro’s board appointment, January 2021 ⁶

No additional independently sourced founder testimonials found beyond Clover Health. The 7wire Ventures website features interviews with portfolio founders through its “Top of the Ladder” series (ConsejoSano’s Abner Mason, NOCD’s Stephen Smith, When Insurance’s Andy Hamilton, GroundGame.Health’s Susan Rawlings Molina), but these are firm-produced content rather than independent testimonials ⁸.

Connections

• Chairperson, American Heart Association National Board of Directors (July 2025–2027) — previously served as Audit Committee Chair and Treasurer; joined AHA circa 2012 through the Qualcomm Life Advisory Council ⁵
• Board member, Clover Health [NASDAQ:CLOV] (January 2021–June 2025) — chaired Audit Committee and Nominating & Corporate Governance Committee; alongside Vivek Garipalli (CEO) ⁶²⁰
• Board member, Medidata Solutions [NASDAQ:MDSO] (May 2011–2019) — served on Audit Committee and Nominating & Governance Committee; until sale to Dassault Systemes ¹⁷⁴
• Board member, Tivity Health [NASDAQ:TVTY] (until May 2020) — chaired Audit Committee, served on Compensation Committee ⁴
• Board member, Click Therapeutics (January 2021–present) ⁴
• Board member, Transcarent — co-hatched with Glen Tullman and Hemant Taneja (General Catalyst) ¹²
• Board member, PayZen ¹⁵
• Board member, Override Health ⁵
• Board member, FOLX Health ⁵
• Board member, Jasper Health ⁵
• Advisory board member, Hippocratic AI (November 2024–present) ²¹
• Advisory board member, Samsung Digital Health ⁴
• Advisory committee member, University of Chicago Innovation Fund ⁴
• Co-founder and board member, The World Innovation Network (TWIN Global) ⁴²²
• Board member, Hopelab — nonprofit focused on youth well-being technology ²³
• Former CFO, Livongo Health [NASDAQ:LVGO] (December 2018–November 2020) — worked alongside Glen Tullman (Executive Chairman) ³⁷
• Former President, Allscripts Healthcare Solutions [NASDAQ:MDRX] (2001–2012) — worked alongside Glen Tullman (CEO) for 12+ years ³⁴
• Co-investor relationship: General Catalyst — Hemant Taneja co-created Transcarent with Shapiro and Tullman ¹²
• Forbes Business Council contributor ⁴
• SXSW 2025 speaker ²⁴
• Frequent podcast guest: StartUp Health NOW, This Week in Health IT, Innovation Rising (Healthbox), Investor Connect, Margin of Care, Garner Health Podcast ⁹²⁵²⁶

Sources